Given the projected deficit of non-malignant hematologists and difficulty recruiting students to this subspecialty [6, 7], this represents a serious long-term consequence for the health-care system. While we note this shortage in the context of hematologist in the United States, this has been ...
“Not every hospital has an apheresis unit, and, unfortunately, not every hematologist knows about gene therapy, let alone about red cell exchange,” adds Condon. “ Just even having the knowledge in the community is going to have a huge impact on how the patient is trea...
Cross-Cultural Medical Care Training and Education: a National Survey of Pediatric Hematology/Oncology Fellows-in-Training and Fellowship Program DirectorsCross-cultural communication trainingPediatric hematologyoncologyTraineesProgram directorsPediatric hematologists/oncologists face complex situations...
Dr Miguel Escobar discusses how hematologists and oncologists can diagnose and treat unexplained bleeds in patients with acquired hemophilia. Listen Interactive Joint Bleed Model Watch an interactive video designed to help you educate patients about joint bleeds, highlight the importance of prompt treatme...
The director is a board- certified hematologist, who has led the program since sickle cell screening implementation. All screening, follow-up, and con- firmatory testing is performed in the local screening center. A nurse and one or two administrative staff are responsible for locating screen ...
Hematologist:A doctor who specializes in blood cancers. Hematopoietic Stem Cell:A cell that develops into any type of specialized blood cell. Hepatomegaly:Enlargement of the liver. JAK 2 (JAK2v617F):The genetic mutation found in approximately 50 percent of myelofibrosis patients, 95 percent of ...
Target Audience: The intended audience for the activities is oncologists, hematologists, and other health care professionals involved in the treatment of patients with non–small cell lung cancer. Learning Objectives: At the conclusion of this activity, participants should be able to: Explain curren...
Target Audience: The intended audience for this activity is oncologists, hematologists, oncology nurses, and other health care professionals involved in the treatment of patients with cancer. Learning Objectives: At the conclusion of this activity, participants should be able to...
Target Audience: The intended audience for this activity is medical oncologists, surgical oncologists, hematologists/oncologists, oncology nurses, and other health care professionals involved in the treatment of patients with glioblastoma. Learning Objectives: A...
Target Audience: The intended audience for the activities is medical oncologists, surgical oncologists, hematologists/oncologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with sarcoma. Learning Objectives: At the conclusion of this a...